BRD9 and pancreatic neoplasm: Altogether, the results using resected patient tumor samples indicated that BRD9 inhibition by a small molecule compound can efficiently target and eliminate the CSC subpopulation of pancreatic cancer cells, thus confirming our prior discoveries on PDAC cell lines.